AUTH:"El Sahly HM" - Search results

Next-Generation SARS-CoV-2 Vaccine Formulations and Alternative Routes of Administration.

J Infect Dis, jiae504, 16 Oct 2024

Cited by: 0 articles | PMID: 39412209

Add to export list

Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.

Fong Y, Dang L, Zhang B, Fintzi J, Chen S, Wang J, Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, [...] Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team

Clin Infect Dis, ciae465, 26 Sep 2024

Cited by: 0 articles | PMID: 39325506

Add to export list

Evaluation of Vancomycin Dose Needed to Achieve 24-Hour Area Under the Concentration-Time Curve to Minimum Inhibitory Concentration Ratio Greater Than or Equal to 400 Using Pharmacometric Approaches in Pediatric Intensive Care Patients.

Jung D, Kishk OA, Bhutta AT, Cummings GE, El Sahly HM, Virk MK, Moffett BS, Morris Daniel JL, Watanabe A, Fishbane N, Kotloff KL, Gu K, Ghazaryan V, Gobburu JVS, Akcan-Arikan A, Campbell JD

Crit Care Explor, 6(10):e1159, 01 Oct 2024

Cited by: 0 articles | PMID: 39352409 | PMCID: PMC11446596

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial.

Zhang B, Fong Y, Fintzi J, Chu E, Janes HE, Kenny A, Carone M, Benkeser D, van der Laan LWP, Deng W, Zhou H, Wang X, Lu Y, Yu C, Borate B, Chen H, Reeder I, Carpp LN, Houchens CR, [...] USG/CoVPN Biostatistics Team

Nat Commun, 15(1):7954, 11 Sep 2024

Cited by: 1 article | PMID: 39261482 | PMCID: PMC11390939

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir.

Singh K, Rubenstein K, Callier V, Shaw-Saliba K, Rupert A, Dewar R, Laverdure S, Highbarger H, Lallemand P, Huang ML, Jerome KR, Sampoleo R, Mills MG, Greninger AL, Juneja K, Porter D, Benson CA, Dempsey W, El Sahly HM, [...] Adaptive COVID-19 Treatment Trial (ACTT-1) Study Group Members

J Infect Dis, 230(3):624-634, 01 Sep 2024

Cited by: 2 articles | PMID: 38657001 | PMCID: PMC11420797

Add to export list Free full text in Europe PMC

Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases.

Baden LR, El Sahly HM, Essink B, Follmann D, Hachigian G, Strout C, Overcash JS, Doblecki-Lewis S, Whitaker JA, Anderson EJ, Neuzil K, Corey L, Priddy F, Tomassini JE, Brown M, Girard B, Stolman D, Urdaneta V, Wang X, [...] COVE Trial Consortium

Nat Commun, 15(1):7469, 29 Aug 2024

Cited by: 0 articles | PMID: 39209823 | PMCID: PMC11362294

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials.

Janes H, Fisher LH, Kee JJ, Parameswaran L, Goepfert PA, Falsey AR, Ludwig J, Magaret CA, Gilbert PB, Kublin JG, Rouphael N, Sobieszczyk ME, El Sahly HM, Baden LR, Grinsztejn B, Walsh SR, Gray GE, Kotloff KL, Gay CL, [...] Huang Y

J Infect Dis, jiae400, 03 Sep 2024

Cited by: 0 articles | PMID: 39225478

Add to export list

COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials.

Sherman AC, Tuan J, Cantos VD, Adeyiga O, Mahoney S, Ortega-Villa AM, Tillman A, Whitaker J, Woodward Davis AS, Leav B, Hirsch I, Sadoff J, Dunkle LM, Gilbert PB, Janes HE, Kublin JG, Goepfert PA, Kotloff K, Rouphael N, [...] Gay CL

Clin Infect Dis, 79(2):364-374, 01 Aug 2024

Cited by: 0 articles | PMID: 38598658

Add to export list

The Promise of New Vaccines Against Respiratory Viruses.

Atmar RL, El Sahly HM

Pediatrics, 153(6):e2023065328, 01 Jun 2024

Cited by: 0 articles | PMID: 38738285

Add to export list

A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults.

Rostad CA, Atmar RL, Walter EB, Frey S, Meier JL, Sherman AC, Lai L, Tsong R, Kao CM, Raabe V, El Sahly HM, Keitel WA, Whitaker JA, Smith MJ, Schmader KE, Swamy GK, Abate G, Winokur P, Buchanan W, [...] Anderson EJ

Clin Infect Dis, 78(6):1757-1768, 01 Jun 2024

Cited by: 1 article | PMID: 38537255

Add to export list

SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials.

Fisher LH, Kee JJ, Liu A, Espinosa CM, Randhawa AK, Ludwig J, Magaret CA, Robinson ST, Gilbert PB, Hyrien O, Kublin JG, Rouphael N, Falsey AR, Sobieszczyk ME, El Sahly HM, Grinsztejn B, Gray GE, Kotloff KL, Gay CL, [...] COVID-19 Prevention Network (CoVPN)

JAMA Netw Open, 7(5):e2412835, 01 May 2024

Cited by: 1 article | PMID: 38780941 | PMCID: PMC11117088

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.

Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X, CORIMUNO-19 Collaborative Group, DisCoVeRy Study Group, ACTT-2 Study Group, ACTT-3 Study Group

EClinicalMedicine, 69:102472, 09 Feb 2024

Cited by: 0 articles | PMID: 38361992 | PMCID: PMC10867612

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial.

El Sahly HM, Yildirim I, Frey SE, Winokur P, Jackson LA, Bernstein DI, Creech CB, Chen WH, Rupp RE, Whitaker JA, Phadke V, Hoft DF, Ince D, Brady RC, Edwards KM, Ortiz JR, Berman MA, Weiss J, Wegel A, DMID 17-0090 Study Group

J Infect Dis, 229(2):327-340, 01 Feb 2024

Cited by: 1 article | PMID: 37466221 | PMCID: PMC10873179

Add to export list Free full text in Europe PMC

Delays in Hepatitis A vaccination in people with HIV in Houston, Texas between 2010 and 2018.

Ciocca ET, Staggers KA, Carey J, Opekun AR, Hollinger FB, Keitel WA, Atmar RL, El Sahly HM, Whitaker JA

Vaccine X, 16:100422, 14 Dec 2023

Cited by: 0 articles | PMID: 38192618 | PMCID: PMC10772366

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.

Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, [...] Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team

J Infect Dis, 228(12):1662-1666, 01 Dec 2023

Cited by: 0 articles | PMID: 37561027 | PMCID: PMC11032204

Add to export list Free full text in Europe PMC

Delays in Hepatitis B Immunization Series Completion in People With Human Immunodeficiency Virus.

Sheikh D, Staggers KA, Carey J, Keitel WA, Atmar RL, El Sahly HM, Whitaker JA

Open Forum Infect Dis, 10(11):ofad543, 03 Nov 2023

Cited by: 1 article | PMID: 38033987 | PMCID: PMC10686353

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial.

Hejazi NS, Shen X, Carpp LN, Benkeser D, Follmann D, Janes HE, Baden LR, El Sahly HM, Deng W, Zhou H, Leav B, Montefiori DC, Gilbert PB

Int J Infect Dis, 137:28-39, 25 Oct 2023

Cited by: 3 articles | PMID: 37820782 | PMCID: PMC10841741

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Risk of COVID-19 after natural infection or vaccination.

Rick AM, Laurens MB, Huang Y, Yu C, Martin TCS, Rodriguez CA, Rostad CA, Maboa RM, Baden LR, El Sahly HM, Grinsztejn B, Gray GE, Gay CL, Gilbert PB, Janes HE, Kublin JG, Huang Y, Leav B, Hirsch I, [...] NIAID-funded COVID-19 Prevention Network (CoVPN)

EBioMedicine, 96:104799, 20 Sep 2023

Cited by: 2 articles | PMID: 37738833 | PMCID: PMC10518569

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Omicron COVID-19 Immune Correlates Analysis of a Third Dose of mRNA-1273 in the COVE Trial

Zhang B, Fong Y, Fintzi J, Chu E, Janes HE, Carpp LN, Kenny A, Carone M, Benkeser D, van der Laan LWP, Deng W, Zhou H, Wang X, Lu Y, Yu C, Borate B, Houchens CR, Martins K, Jayashankar L, [...] USG/CoVPN Biostatistics Team

medRxiv, 15 Oct 2023

Cited by: 0 articles | PPR: PPR742475

Add to export list Preprint

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial.

Huang Y, Hejazi NS, Blette B, Carpp LN, Benkeser D, Montefiori DC, McDermott AB, Fong Y, Janes HE, Deng W, Zhou H, Houchens CR, Martins K, Jayashankar L, Flach B, Lin BC, O'Connell S, McDanal C, Eaton A, [...] United States Government Usg/CoVPN Biostatistics Teams

Viruses, 15(10):2029, 29 Sep 2023

Cited by: 5 articles | PMID: 37896806 | PMCID: PMC10612023

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Identification of immunodominant T cell epitopes induced by natural Zika virus infection.

Eickhoff CS, Meza KA, Terry FE, Colbert CG, Blazevic A, Gutiérrez AH, Stone ET, Brien JD, Pinto AK, El Sahly HM, Mulligan MJ, Rouphael N, Alcaide ML, Tomashek KM, Focht C, Martin WD, Moise L, De Groot AS, Hoft DF

Front Immunol, 14:1247876, 29 Aug 2023

Cited by: 5 articles | PMID: 37705976 | PMCID: PMC10497216

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.

Branche AR, Rouphael NG, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Anderson EJ, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, [...] COVAIL Study Group

Nat Med, 29(9):2334-2346, 28 Aug 2023

Cited by: 16 articles | PMID: 37640860 | PMCID: PMC10504073

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials.

Theodore DA, Branche AR, Zhang L, Graciaa DS, Choudhary M, Hatlen TJ, Osman R, Babu TM, Robinson ST, Gilbert PB, Follmann D, Janes H, Kublin JG, Baden LR, Goepfert P, Gray GE, Grinsztejn B, Kotloff KL, Gay CL, [...] COVID-19 Prevention Network (CoVPN)

JAMA Netw Open, 6(7):e2323349, 03 Jul 2023

Cited by: 8 articles | PMID: 37440227 | PMCID: PMC10346130

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants.

Lyke KE, Atmar RL, Dominguez Islas C, Posavad CM, Deming ME, Branche AR, Johnston C, El Sahly HM, Edupuganti S, Mulligan MJ, Jackson LA, Rupp RE, Rostad CA, Coler RN, Bäcker M, Kottkamp AC, Babu TM, Dobrzynski D, Martin JM, [...] DMID 21-0012 Study Group

NPJ Vaccines, 8(1):98, 11 Jul 2023

Cited by: 9 articles | PMID: 37433788 | PMCID: PMC10336079

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Cumulative Febrile, Respiratory, and Gastrointestinal Illness Among Infants in Rural Guatemala and Association With Neurodevelopmental and Growth Outcomes.

Olson D, Lamb MM, Connery AK, Colbert AM, Calvimontes DM, Bauer D, Paniagua-Avila MA, Martínez MA, Arroyave P, Hernandez S, Colborn KL, Roell Y, Waggoner JJ, Natrajan MS, Anderson EJ, Bolaños GA, El Sahly HM, Munoz FM, Asturias EJ

Pediatr Infect Dis J, 42(9):739-744, 21 Jun 2023

Cited by: 0 articles | PMID: 37343218 | PMCID: PMC10527407

Add to export list Free full text in Europe PMC

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

Next-Generation SARS-CoV-2 Vaccine Formulations and Alternative Routes of Administration.

Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.

Evaluation of Vancomycin Dose Needed to Achieve 24-Hour Area Under the Concentration-Time Curve to Minimum Inhibitory Concentration Ratio Greater Than or Equal to 400 Using Pharmacometric Approaches in Pediatric Intensive Care Patients.

Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial.

SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir.

Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases.

Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials.

COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials.

The Promise of New Vaccines Against Respiratory Viruses.

A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults.

SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials.

Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.

Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial.

Delays in Hepatitis A vaccination in people with HIV in Houston, Texas between 2010 and 2018.

Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.

Delays in Hepatitis B Immunization Series Completion in People With Human Immunodeficiency Virus.

Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial.

Risk of COVID-19 after natural infection or vaccination.

Omicron COVID-19 Immune Correlates Analysis of a Third Dose of mRNA-1273 in the COVE Trial

Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial.

Identification of immunodominant T cell epitopes induced by natural Zika virus infection.

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.

Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials.

Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants.

Cumulative Febrile, Respiratory, and Gastrointestinal Illness Among Infants in Rural Guatemala and Association With Neurodevelopmental and Growth Outcomes.

Partnerships & funding